What Every Pharmaceuticals Stakeholder Should Know

Today, manufacturers face many challenges and opportunities when dealing with the innovative approaches to demonstrate a value and affordability of a pharmaceutical product to other stakeholders.

Key elements for successful delivery of value and affordability include market access and HTA (Health Technology Assessment).

Market access is a process of identifying, creating and communication value to the key stakeholders. The global value needs to reflect on a local level, thus remaining relevant to the local setting. The setting specific value is reflected through HTA processes.

The course will consist of theoretical sessions followed by practical workshops. It will cover key HTA concepts and provide an overview of methods used in the evaluation of medical technology during pricing and reimbursement decision making process. The practical workshops will allow participants to develop skills to interpret HTA findings and build pricing and reimbursement strategy based on HTA outcomes. In the end of the course, participants will be able to create pharmaceutical product local value propositions.

What you will learn

At the conclusion of this course, participants should be able to:

Understand the role of HTA in the pricing and reimbursement decision making processes in the healthcare sector and apply the principles in the local and global contexts

Discuss an overview of clinical evidence and economic evidence and identify methods for evidence searching, review and grading

Develop value proposition for the pharmaceutical product

Learning objectives will be achieved using a mix of theoretical and practical approaches. Theoretical components will include PowerPoint presentations, live demonstration of key aspects and guest speaker presentation. Practical working exercises will include guided group discussions, case study analysis and participant feedback